{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:18:18Z","timestamp":1791839898156,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,22]]},"DOI":"10.7759\/cureus.9933","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T12:10:32Z","timestamp":1598098232000},"source":"Crossref","is-referenced-by-count":6,"title":["Parkinson\u2019s Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis?"],"prefix":"10.7759","author":[{"given":"Puja","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Raj","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Alhumaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Chaitanya","family":"Bollampally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal Haider","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson's disease","volume":"30","author":"Lebouvier T","year":"2009","unstructured":"Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, des Varannes SB, Neunlist M, Derkinderen P. The second brain and Parkinson's disease. Eur J Neurosci. 2009, 30:735-741. 10.1111\/j.1460-9568.2009.06873.x","journal-title":"Eur J Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"E Ray Dorsey","year":"2016","unstructured":"E Ray Dorsey, Alexis Elbaz, Emma Nichols, et al.. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2016, 17:939-953. 10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4382518","article-title":"Nonmotor symptoms of Parkinson's disease","volume":"2017","author":"Wu SL","year":"2017","unstructured":"Wu SL,  Liscic RM, Kim SY, Sorbi S, Yang YH. Nonmotor symptoms of Parkinson's disease. 2017, 2017:10.1155\/2017\/4382518"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24051","article-title":"Toward a redefinition of Parkinson's disease","volume":"27","author":"Stern MB","year":"2012","unstructured":"Stern MB, Lang A, Poewe W. Toward a redefinition of Parkinson's disease.  Mov Disord. 2012, 27:54-60. 10.1002\/mds.24051","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S130319","article-title":"Skin disorders in Parkinson's disease: potential biomarkers and risk factors","volume":"10","author":"Ravn AH","year":"2017","unstructured":"Ravn AH, Thyssen JP, Egeberg A. Skin disorders in Parkinson's disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017, 10:87-92. 10.2147\/CCID.S130319","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-14-5","article-title":"A laboratory-based study on patients with Parkinson\u2019s disease and seborrheic dermatitis: the presence and density of malassezia yeasts, their different species and enzymes production","volume":"14","author":"Arsic Arsenijevic VS","year":"2014","unstructured":"Arsic Arsenijevic VS, Milobratovic D, Barac AM, Vekic B, Marinkovic J, Kostic VS. A laboratory-based study on patients with Parkinson\u2019s disease and seborrheic dermatitis: the presence and density of malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014, 14:5. 10.1186\/1471-5945-14-5","journal-title":"BMC Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00758","article-title":"Malassezia and Parkinson's disease","volume":"24","author":"Laurence M","year":"2019","unstructured":"Laurence M, Benito-Le\u00f3n J, Calon F. Malassezia and Parkinson's disease. Front Neurol. 2019, 24:758. 10.3389\/fneur.2019.00758","journal-title":"Front Neurol"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.3109\/13693786.2013.820001","article-title":"Seborrheic dermatitis: predisposing factors and ITS2 secondary structure for malassezia phylogenic analysis","volume":"51","author":"Amado Y","year":"2013","unstructured":"Amado Y, Pati\u00f1o-Uzc\u00e1tegui A, Cepero de Garc\u00eda MC, et al.. Seborrheic dermatitis: predisposing factors and ITS2 secondary structure for malassezia phylogenic analysis. Med Mycol. 2013, 51:868-875.","journal-title":"Med Mycol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12682040","article-title":"Sebaceous gland excretion in parkinson\u2019s disease during l-dopa treatment","volume":"60","author":"Kohn SR","year":"1973","unstructured":"Kohn SR, Pochi PE, Strauss JS, Sax DS, Feldman RG, Timberlake WH. Sebaceous gland excretion in parkinson\u2019s disease during l-dopa treatment. J Invest Dermatol. 1973, 60:134-136. 10.1111\/1523-1747.ep12682040","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF01294730","article-title":"Is seborrhea a sign of autonomic impairment in Parkinson\u2019s disease?","volume":"104","author":"Martignoni E","year":"1997","unstructured":"Martignoni E, Godi L, Pacchetti C et al.. Is seborrhea a sign of autonomic impairment in Parkinson\u2019s disease?. J Neural Transm. 1997, 104:1295-1304. 10.1007\/BF01294730","journal-title":"J Neural Transm"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.S42.001","article-title":"Seborrheic dermatitis and risk of future Parkinson\u2019s disease","volume":"78","author":"Tanner C","year":"2012","unstructured":"Tanner C, Albers K, Goldman S, Fross R, Leimpeter A, Klingman J, Van Den Eeden S. Seborrheic dermatitis and risk of future Parkinson\u2019s disease. Neurology. 2012, 78:S42.001-S42.001.","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2017.78.6.C88","article-title":"Seborrhoeic dermatitis","volume":"78","author":"Ijaz N","year":"2017","unstructured":"Ijaz N, Fitzgerald D. Seborrhoeic dermatitis. Br J Hosp Med. 2017, 78:88-91. 10.12968\/hmed.2017.78.6.C88","journal-title":"Br J Hosp Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03470.x","article-title":"Seborrheic dermatitis among Oxford renal transplant recipients","volume":"24","author":"Lally A","year":"2010","unstructured":"Lally A, Casabonne D, Newton R, Wojnarowska F. Seborrheic dermatitis among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol. 2010, 24:561-564. 10.1111\/j.1468-3083.2009.03470.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/srep33738","article-title":"Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with parkinson\u2019s disease","author":"Kustrimovic N","year":"2016","unstructured":"Kustrimovic N, Rasini E, Legnaro M, et al.. Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with parkinson\u2019s disease. Sci Rep. 2016, 33738. 10.1038\/srep33738","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF02505250","article-title":"Effects of pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN\u03b3) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis","volume":"288","author":"Neuber K","year":"1996","unstructured":"Neuber K, Kr\u00f6ger S, Gruseck E, Abeck D, Ring J. Effects of pityrosporum ovale on proliferation, immunoglobulin (IgA, G, M) synthesis and cytokine (IL-2, IL-10, IFN\u03b3) production of peripheral blood mononuclear cells from patients with seborrhoeic dermatitis. Arch Dermatol Res. 1996, 288:532-536. 10.1007\/BF02505250","journal-title":"Arch Dermatol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/19381980.2017.1361574","article-title":"Rosacea: epidemiology, pathogenesis, and treatment","volume":"9","author":"Rainer BM","year":"2017","unstructured":"Rainer BM, Kang S, Chien AL. Rosacea: epidemiology, pathogenesis, and treatment.  Dermatoendocrinol. 2017, 9:1361574-2017. 10.1080\/19381980.2017.1361574","journal-title":"Dermatoendocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s007020170088","article-title":"Skin function and skin disorders in parkinson\u2019s disease","volume":"108","author":"Fischer M","year":"2001","unstructured":"Fischer M, Gemende I, Marsch WC, Fischer PA. Skin function and skin disorders in parkinson\u2019s disease. J Neural Transm. 2001, 108:205-213. 10.1007\/s007020170088","journal-title":"J Neural Transm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0022","article-title":"Exploring the association between rosacea and parkinson disease: a Danish nationwide cohort study","volume":"73","author":"Egeberg A","year":"2016","unstructured":"Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Exploring the association between rosacea and parkinson disease: a Danish nationwide cohort study. JAMA Neurol. 2016, 73:529-534. 10.1001\/jamaneurol.2016.0022","journal-title":"JAMA Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14638","article-title":"Rosacea and subsequent diagnosis for Parkinson's disease: a large, urban, single center, US patient population retrospective study","volume":"32","author":"Mathieu RJ","year":"2017","unstructured":"Mathieu RJ, Guido N, Ibler E, et al.. Rosacea and subsequent diagnosis for Parkinson's disease: a large, urban, single center, US patient population retrospective study. J Eur Acad Dermatol Venereol. 2017, 32:141-144. 10.1111\/jdv.14638","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03825.x","article-title":"Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea","volume":"25","author":"Jang YH","year":"2011","unstructured":"Jang YH, Sim JH, Kang HY, Kim YC, Lee ES. Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea. J Eur Acad Dermatol Venereol. 2011, 25:544-548. 10.1111\/j.1468-3083.2010.03825.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/370526","article-title":"MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease","volume":"2013","author":"Chung YC","year":"2013","unstructured":"Chung YC, Kim YS, Bok E, Yune TY, Maeng S, Jin BK. MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson\u2019s disease. Mediators Inflamm. 2013, 2013:370526.","journal-title":"Mediators Inflamm"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2017.12.003","article-title":"Parkinson's disease pathogenesis, evolution and alternative pathways: a review","volume":"174","author":"Alexoudi A","year":"2018","unstructured":"Alexoudi A, Alexoudi I, Gatzonis S. Parkinson's disease pathogenesis, evolution and alternative pathways: a review. Rev Neurol. 2018, 174:699-704. 10.1016\/j.neurol.2017.12.003","journal-title":"Rev Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"14","author":"Fasano A","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015, 14:625-639. 10.1016\/S1474-4422(15)00007-1","journal-title":"Lancet Neurol"},{"key":"ref24","article-title":"Assessment of tachykinin receptor 3' gene polymorphism rs3733631 in rosacea","volume":"2015","author":"Karpouzis A","year":"2015","unstructured":"Karpouzis A, Avgeridis P, Tripsianis G, Gatzidou E, Kourmouli N, Veletza S. Assessment of tachykinin receptor 3' gene polymorphism rs3733631 in rosacea. Int Sch Res Notices. 2015, 2015:469402-10.","journal-title":"Int Sch Res Notices"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22496","article-title":"Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model","volume":"61","author":"Lazzarini M","year":"2013","unstructured":"Lazzarini M, Martin S, Mitkovski M, Vozari RR, Stuhmer W, Bel ED. Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model. GLIA. 2013, 61:1084-1100. 10.1002\/glia.22496","journal-title":"GLIA"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard P","year":"2017","unstructured":"Bernard P, Antonicelli F. Bullous pemphigoid: a review of its diagnosis, associations and treatment. Am J Clin Dermatol. 2017, 18:513-528. 10.1007\/s40257-017-0264-2","journal-title":"Am J Clin Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1772-x","article-title":"Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland","volume":"309","author":"Kalinska-Bienias A","year":"2017","unstructured":"Kalinska-Bienias A, Lukowska-Smorawska K, Jagielski P, Kowalewski C, Wozniak K. Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland. Arch Dermatol Res. 2017, 309:709-719. 10.1007\/s00403-017-1772-x","journal-title":"Arch Dermatol Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12806","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the national skin centre","volume":"170","author":"Cai SC","year":"2014","unstructured":"Cai SC, Allen JC, Lim YL, Chua SH, Tan SH, Tang MB. Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the national skin centre. Br J Dermatol. 2014, 170:1319-1326. 10.1111\/bjd.12806","journal-title":"Br J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13660","article-title":"Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis","volume":"30","author":"Lai YC","year":"2016","unstructured":"Lai YC, Yew YW, Lambert WC. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2016, 30:2007-2015. 10.1111\/jdv.13660","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2017.3066","article-title":"The association between bullous pemphigoid and neurological disorders: a systematic review","volume":"27","author":"Milani-Nejad N","year":"2017","unstructured":"Milani-Nejad N, Zhang M, Kaffenberger J. The association between bullous pemphigoid and neurological disorders: a systematic review. Eur J Dermatol. 2017, 27:472-481. 10.1684\/ejd.2017.3066","journal-title":"Eur J Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2005.11.004","article-title":"Collagen XVII is expressed in human CNS neurons","volume":"25","author":"Seppanen A","year":"2006","unstructured":"Seppanen A, Autio-Harmainen H, Alafuzoff I, et al.. Collagen XVII is expressed in human CNS neurons. Matrix Biol. 2006, 25:185-188. 10.1016\/j.matbio.2005.11.004","journal-title":"Matrix Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12877","article-title":"One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1","volume":"25","author":"Kunzli K","year":"2016","unstructured":"Kunzli K, Favre B, Chofflon M,  Borradori L. One gene but different proteins and diseases: the complexity of dystonin and bullous pemphigoid antigen 1. Exp Dermatol. 2016, 25:10-16. 10.1111\/exd.12877","journal-title":"Exp Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13401","article-title":"Neurological and psychiatric associations in bullous pemphigoid - more than skin deep?","volume":"26","author":"F\u00f6rsti AK","year":"2017","unstructured":"F\u00f6rsti AK, Huilaja L, Schmidt E, Tasanen K. Neurological and psychiatric associations in bullous pemphigoid - more than skin deep?. Exp Dermatol. 2017, 26:1228-1234. 10.1111\/exd.13401","journal-title":"Exp Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.12.005","article-title":"Autoantibodies to collagen XVII are present in Parkinson's disease and localize to tyrosine-hydroxylase positive neurons","volume":"136","author":"Messingham K A","year":"2016","unstructured":"Messingham K A, Aust S, Helfenberger J, et al.. Autoantibodies to collagen XVII are present in Parkinson's disease and localize to tyrosine-hydroxylase positive neurons. J Invest Dermatol. 2016, 136:721-723. 10.1016\/j.jid.2015.12.005","journal-title":"J Invest Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/srep37125","article-title":"Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish care register study","volume":"6","author":"Forsti AK","year":"2016","unstructured":"Forsti AK, Jokelainen J, Ansakorpi H, Sepp\u00e4nen A, Majamaa K, Timonen M, Tasanen K. Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish care register study. Sci Rep. 2016, 6:37125. 10.1038\/srep37125","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-171263","article-title":"Parkinson's disease and melanoma co-occurrence and mechanisms","volume":"8","author":"Bose A","year":"2018","unstructured":"Bose A, Petsko GA, Eliezer D. Parkinson's disease and melanoma co-occurrence and mechanisms. J Parkinsons Dis. 2018, 8:385-398. 10.3233\/JPD-171263","journal-title":"J Parkinsons Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031","volume":"136","author":"Whiteman DC","year":"2016","unstructured":"Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016, 136:1161-1171. 10.1016\/j.jid.2016.01.035","journal-title":"J Invest Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.03.014","article-title":"Parkinson disease and melanoma: confirming and reexamining an association","volume":"92","author":"Dalvin LA","year":"2017","unstructured":"Dalvin LA, Damento GM, Yawn BP, Abbott BA, Hodge DO, Pulido JS. Parkinson disease and melanoma: confirming and reexamining an association. Mayo Clin Proc. 2017, 92:1070-1079. 10.1016\/j.mayocp.2017.03.014","journal-title":"Mayo Clin Proc"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25734","article-title":"Malignant melanoma in early-treated parkinson\u2019s disease: the NET-PD trial","volume":"29","author":"Constantinescu R","year":"2014","unstructured":"Constantinescu R, Elm J, Auinger P, et al.. Malignant melanoma in early-treated parkinson\u2019s disease: the NET-PD trial. Mov Disord. 2014, 29:263-265. 10.1002\/mds.25734","journal-title":"Mov Disord"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bd13a1","article-title":"Family history of melanoma and parkinson disease risk","volume":"73","author":"Gao X","year":"2009","unstructured":"Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A. Family history of melanoma and parkinson disease risk. Neurology. 2009, 73:1286-1291. 10.1212\/WNL.0b013e3181bd13a1","journal-title":"Neurology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3109\/00207459208986663","article-title":"Accelerated growth of malignant melanoma by levodopa in Parkinson\u2019s disease and role of the pineal gland","volume":"63","author":"Sandyk R","year":"1992","unstructured":"Sandyk R. Accelerated growth of malignant melanoma by levodopa in Parkinson\u2019s disease and role of the pineal gland. Int J Neurosci. 1992, 63:137-140. 10.3109\/00207459208986663","journal-title":"Int J Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21273","article-title":"Malignant melanoma in early Parkinson\u2019s disease: the DATATOP trial","volume":"22","author":"Constantinescu R","year":"2007","unstructured":"Constantinescu R, Romer M, Kieburtz K, et al.. Malignant melanoma in early Parkinson\u2019s disease: the DATATOP trial. Mov Disord. 2007, 22:720-722. 10.1002\/mds.21273","journal-title":"Mov Disord"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease","volume":"131","author":"Pan T","year":"2008","unstructured":"Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease. Brain. 2008, 131:1969-1978. 10.1093\/brain\/awm318","journal-title":"Brain"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2008.07.014","article-title":"Autophagy: a lysosomal degradation pathway with a central role in health and disease","volume":"1793","author":"Eskelinen EL","year":"2009","unstructured":"Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta. 2009, 1793:664-673. 10.1016\/j.bbamcr.2008.07.014","journal-title":"Biochim Biophys Acta"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu J","year":"2002","unstructured":"Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med. 2002, 8:600-606. 10.1038\/nm0602-600","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.02481","article-title":"Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells","volume":"118","author":"Peng X","year":"2005","unstructured":"Peng X, Peng XM, Tehranian R, Dietrich P, Stefanis L, Perez RG. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci. 2005, 118:3523-3530. 10.1242\/jcs.02481","journal-title":"J Cell Sci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M709014200","article-title":"The reaction of alphasynuclein with tyrosinase: possible implications for Parkinson disease","volume":"283","author":"Tessari I","year":"2008","unstructured":"Tessari I, Bisaglia M, Valle F, Samor\u00ec B, Bergantino E, Mammi S, Bubacco L. The reaction of alphasynuclein with tyrosinase: possible implications for Parkinson disease. J Biol Chem. 2008, 283:16808-16817. 10.1074\/jbc.M709014200","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24373","article-title":"The MC1R melanoma risk variant p.R160W is associated with Parkinson disease","volume":"77","author":"Tell-Marti G","year":"2015","unstructured":"Tell-Marti G, Puig-Butille JA, Potrony M, et al.. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease. Ann Neurol. 2015, 77:889-894.","journal-title":"Ann Neurol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0931262100","article-title":"Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27","volume":"100","author":"Cesari R","year":"2003","unstructured":"Cesari R, Martin ES, Calin GA, et al.. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A. 2003, 100:5956-5961. 10.1073\/pnas.0931262100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","article-title":"Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma","volume":"51","author":"Millikin D","year":"1991","unstructured":"Millikin D, Meese E, Vogelstein B, Witkowski C, Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res. 1991, 51:5449-5453.","journal-title":"Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36887-parkinsons-disease-and-its-dermatological-associations-is-your-skin-whispering-you-a-diagnosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:34Z","timestamp":1707506674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36887-parkinsons-disease-and-its-dermatological-associations-is-your-skin-whispering-you-a-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,22]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.9933","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,22]]}}}